Onderneming Phoenix Life Sciences International Limited Other OTC
Aandelen
PLSI
US71910Q1022
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Janelle Marsden
CEO | Chief Executive Officer | - | - |
Lewis Humer
CHM | Chairman | 65 | 25-04-14 |
Stephen Cornford
CIO | Chief Investment Officer | - | - |
David Steinman
LAW | General Counsel | - | 01-02-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lewis Humer
CHM | Chairman | 65 | 25-04-14 |
Janelle Marsden
CEO | Chief Executive Officer | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 10 084 582 | 8 644 192 ( 85,72 %) | 0 | 85,72 % |
Bedrijfsgegevens
Phoenix Life Sciences International Ltd.
1810 East Sahara Avenue Suite 215
89139, Las Vegas
+
http://www.phoenixlife.coSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,73% | 739 mld. | |
+32,83% | 598 mld. | |
-6,30% | 353 mld. | |
+15,15% | 318 mld. | |
+4,05% | 285 mld. | |
+15,00% | 240 mld. | |
-5,52% | 206 mld. | |
+6,17% | 164 mld. | |
-0,45% | 162 mld. |